These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15943554)

  • 1. Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families.
    Grabowski M; Mueller-Koch Y; Grasbon-Frodl E; Koehler U; Keller G; Vogelsang H; Dietmaier W; Kopp R; Siebers U; Schmitt W; Neitzel B; Gruber M; Doerner C; Kerker B; Ruemmele P; Henke G; Holinski-Feder E
    Genet Test; 2005; 9(2):138-46. PubMed ID: 15943554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country.
    Martínez-Bouzas C; Ojembarrena E; Beristain E; Errasti J; Viguera N; Tejada Minguéz MI
    Cancer Lett; 2007 Oct; 255(2):295-9. PubMed ID: 17582678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.
    Zavodna K; Krivulcik T; Bujalkova MG; Slamka T; Martinicky D; Ilencikova D; Bartosova Z
    BMC Cancer; 2009 Nov; 9():405. PubMed ID: 19930554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary nonpolyposis colorectal cancer: pitfalls in deletion screening in MSH2 and MLH1 genes.
    Wehner M; Mangold E; Sengteller M; Friedrichs N; Aretz S; Friedl W; Propping P; Pagenstecher C
    Eur J Hum Genet; 2005 Aug; 13(8):983-6. PubMed ID: 15870828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.
    Kovacs ME; Papp J; Szentirmay Z; Otto S; Olah E
    Hum Mutat; 2009 Feb; 30(2):197-203. PubMed ID: 19177550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype.
    Pérez-Cabornero L; Borrás Flores E; Infante Sanz M; Velasco Sampedro E; Acedo Becares A; Lastra Aras E; Cuevas González J; Pineda Riu M; Ramón y Cajal Asensio T; Capellá Munar G; Miner Pino C; Durán Domínguez M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1546-55. PubMed ID: 21778331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination.
    Aissi-Ben Moussa S; Moussa A; Lovecchio T; Kourda N; Najjar T; Ben Jilani S; El Gaaied A; Porchet N; Manai M; Buisine MP
    Fam Cancer; 2009; 8(2):119-26. PubMed ID: 18792805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer.
    Baert-Desurmont S; Buisine MP; Bessenay E; Frerot S; Lovecchio T; Martin C; Olschwang S; Wang Q; Frebourg T
    Eur J Hum Genet; 2007 Mar; 15(3):383-6. PubMed ID: 17228328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large genomic rearrangements and germline epimutations in Lynch syndrome.
    Gylling A; Ridanpää M; Vierimaa O; Aittomäki K; Avela K; Kääriäinen H; Laivuori H; Pöyhönen M; Sallinen SL; Wallgren-Pettersson C; Järvinen HJ; Mecklin JP; Peltomäki P
    Int J Cancer; 2009 May; 124(10):2333-40. PubMed ID: 19173287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.
    Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G
    Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
    Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
    Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
    Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
    Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families.
    Brea-Fernández AJ; Cameselle-Teijeiro JM; Alenda C; Fernández-Rozadilla C; Cubiella J; Clofent J; Reñé JM; Anido U; Milá M; Balaguer F; Castells A; Castellvi-Bel S; Jover R; Carracedo A; Ruiz-Ponte C
    Clin Genet; 2014 Jun; 85(6):583-8. PubMed ID: 23837913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large MSH2 Alu insertion mutation causes HNPCC in a German kindred.
    Kloor M; Sutter C; Wentzensen N; Cremer FW; Buckowitz A; Keller M; von Knebel Doeberitz M; Gebert J
    Hum Genet; 2004 Oct; 115(5):432-8. PubMed ID: 15340835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel heterozygous large deletion of MSH6 gene in a Chinese family with Lynch syndrome.
    Liu Y; Wang M; Chen Q; Zheng Q; Li G; Cheng Q; Liu S; Ye S
    Gene; 2019 Jul; 704():103-112. PubMed ID: 30974197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic study on genetic and epimutational profile of a cohort of Amsterdam criteria-defined Lynch Syndrome in Singapore.
    Liu Y; Chew MH; Goh XW; Tan SY; Loi CT; Tan YM; Law HY; Koh PK; Tang CL
    PLoS One; 2014; 9(4):e94170. PubMed ID: 24710284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different molecular mechanisms underlie genomic deletions in the MLH1 Gene.
    Viel A; Petronzelli F; Della Puppa L; Lucci-Cordisco E; Fornasarig M; Pucciarelli S; Rovella V; Quaia M; Ponz de Leon M; Boiocchi M; Genuardi M
    Hum Mutat; 2002 Nov; 20(5):368-74. PubMed ID: 12402334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.
    Kloor M; Voigt AY; Schackert HK; Schirmacher P; von Knebel Doeberitz M; Bläker H
    J Clin Oncol; 2011 Jan; 29(2):223-7. PubMed ID: 21115857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation of single exon deletions in MLH1 and MSH2 using quantitative polymerase chain reaction.
    Vaughn CP; Lyon E; Samowitz WS
    J Mol Diagn; 2008 Jul; 10(4):355-60. PubMed ID: 18556772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.